XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock
Common stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury stock
Treasury stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance, beginning of period (in shares) at Dec. 31, 2021       19,903,342                    
Balance, beginning of period at Dec. 31, 2021 $ 524,038     $ 2   $ 261,905   $ (38,148)   $ 298,615     $ 1,664  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Share-based compensation, net of forfeitures 166         166                
Net income 7,669                 7,669        
Other comprehensive income (loss) (16,332)                       (16,332)  
Balance, end of period (in shares) at Mar. 31, 2022       19,903,342                    
Balance, ending of period at Mar. 31, 2022 $ 515,541     $ 2   262,071   (38,148)   306,284     (14,668)  
Balance, beginning of period (in shares) at Dec. 31, 2022 24,920,984     24,920,984                    
Balance, beginning of period at Dec. 31, 2022 $ 774,536 $ (3,808) $ 770,728 $ 2 $ 2 460,720 $ 460,720 0 $ 0 357,797 $ (3,808) $ 353,989 (43,983) $ (43,983)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock on restricted stock grants 101         101                
Stock option exercises (in shares)       3,039                    
Stock option exercises 27         27                
Share-based compensation, net of forfeitures 326         326                
Net income 26,281                 26,281        
Other comprehensive income (loss) $ 1,587                       1,587  
Balance, end of period (in shares) at Mar. 31, 2023 24,924,023     24,924,023                    
Balance, ending of period at Mar. 31, 2023 $ 799,050     $ 2   $ 461,174   $ 0   $ 380,270     $ (42,396)